Since we have known each other, Irina has been consistently impressive in her ability to build cases, design BD strategies and appropriately implement them. Among the European Biotech community she is one of the few BD consultants with a solid track record of significant achievements. As investors, we never hesitate to invite our portfolio companies to check her out.